Eli Lilly and Company (LLY.SW)
Makes insulin and cancer medicines sold worldwide.
1,010.00+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+61.6%
The outlook
Eli Lilly trades near its 52-week high, well above both its 50- and 200-day moving averages, reflecting a strong uptrend. Analyst coverage appears thin on this Swiss listing. The stock carries a trailing P/E of 43.9, notably elevated relative to broader market averages.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$900.66B
52-wk high
1,010.00
52-wk low
560.00
50-day avg
916.80
200-day avg
814.35
Trailing P/E
43.9